TheLeadLeft

2021: Injections and Projections

What have you missed most over the past few months? Well, if you said “Grape-Nuts” we feel your pain. Our beloved cereal has gone missing from supermarket shelves across the US. First produced in 1897 Grape-Nuts accompanied Sir Admiral Byrd to Antarctica and Sir Edmund Hillary to Mount Everest. But don’t worry. They’ll be back. […]

The Pulse of Private Equity – 2/22/2021

Big bumps in IRR data PE returns bounced back in a big way in mid-2020, according to PitchBook’s upcoming Global Fund Performance Report. After cratering by -8.32% in the first quarter, IRRs were above 9% in both Q2 and Q3. The third quarter mark of 9.81% is preliminary data, but it would be the highest…

Debtwire Middle-Market – 2/22/2021

LIBOR floors shift lower in borrower friendly market Source: Debtwire Par The percentage of loans issued with a 1% LIBOR floor or greater has continued to decline, driven in no small part by the wave of repricings hitting the loan market this year – loan repricings have made up a whopping 49% of the USD…

Private Debt Intelligence - 2/22/2021

Private Debt near-terms IRRs decline In comparison to its peers, private debt lags over short- and mid-term investment horizons. A downturn in Q1 2020 pulled the private debt asset class down to a one-year IRR of -0.8% to the end of June…. Subscribe to Read MoreAlready a member? Log in here...

2021: The Great Reception (Second of a Series)

We continue our special series on the outlook for the year ahead with a look at the capital markets. What are the moving parts impacting funds flow, asset characteristics (volume, prices, and yields), and quality of deal issuance? With each passing day, the prospect for lower infection rates improves. Investors expect vaccine distribution to reach…